Skip to main content

Yubin Kang

Professor of Medicine
Medicine, Hematologic Malignancies and Cellular Therapy
Box 3961 Med Ctr, Durham, NC 27710
Hematologic Malignancies, Box 3961, Durham, NC 27710

Current Appointments & Affiliations


Professor of Medicine · 2021 - Present Medicine, Hematologic Malignancies and Cellular Therapy, Medicine
Member of the Duke Cancer Institute · 2013 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Chromatin Remodeling in Patient-Derived Colorectal Cancer Models.

Conference Advanced science (Weinheim, Baden-Wurttemberg, Germany) · April 2024 Patient-Derived Organoids (PDO) and Xenografts (PDX) are the current gold standards for patient-derived models of cancer (PDMC). Nevertheless, how patient tumor cells evolve in these models and the impact on drug response remains unclear. Herein, the trans ... Full text Cite

Longitudinal intravital imaging of mouse placenta.

Journal Article Sci Adv · March 22, 2024 Studying placental functions is crucial for understanding pregnancy complications. However, imaging placenta is challenging due to its depth, volume, and motion distortions. In this study, we have developed an implantable placenta window in mice that enabl ... Full text Open Access Link to item Cite

Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

Journal Article J Natl Compr Canc Netw · January 2024 The treatment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) has evolved to include several new options. The NCCN Guidelines for WM/LPL provide a framework on which to base decisions regarding diagnosis, treatment, assessment of respo ... Full text Link to item Cite
View All Publications

Education, Training & Certifications


Shanghai Second Medical University (China) · 1991 M.D.